Lucintel Forecasts the Global Baculovirus Expression System Market is expected to grow with a CAGR of 8.5% from 2024 to 2030
Lucintel Forecasts the Global Baculovirus Expression System Market is expected to grow with a CAGR of 8.5% from 2024 to 2030
Blog Article
According to a market report by Lucintel, the future of the global baculovirus expression system market looks promising with opportunities in the biopharmaceutical company, academic and research institution, and contract research organization markets. The global baculovirus expression system market is expected to grow with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are rising frequency of chronic diseases such as cancer, autoimmune disorders, and infectious diseases, growing acceptability of gene therapy and vaccine development, and rising demand for recombinant proteins.
A more than 150-page report to understand trends, opportunity and forecast in baculovirus expression system market to 2030 by expression host (Sf9 cells, Sf21 cells, and others), expression type (protein expression and vaccine production), application (recombinant protein production, vaccine development, gene therapy, enzyme production, and others), end use (biopharmaceutical companies, academic and research institutions, contract research organizations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)
Lucintel forecasts that, within the application category, recombinant protein production is expected to witness the highest growth over the forecast period due to baculovirus expression system consistently yields high quantities of the desired protein, crucial for industrial manufacturing or large-scale research projects.
Within the end use category, biopharmaceutical company will remain the largest segment due to the use of baculovirus expression system for the creation of medicinal proteins, vaccines, and drugs.
Download sample by clicking on baculovirus expression system market
In terms of regions, North America will remain the largest region over the forecast period due to rapid adoption of advanced technologies, significant r&d investment, and the existence of prominent biopharma companies.
Thermo Fisher Scientific, Merck, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega, Qiagen, Bio-Rad Laboratories, New England Biolabs, Genscript Biotech are the major suppliers in the baculovirus expression system market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.comTo get access of more than 1000 reports at fraction of cost visit Lucintel'sAnalytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Capnography Device Market
Electrosurgery Market
Equine Surgery Market
Mussel Oil & Powder Market
Ocular Surgery Market